4//SEC Filing
Crombez Eric 4
Accession 0001209191-17-059624
CIK 0001592288other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 5:05 PM ET
Size
13.1 KB
Accession
0001209191-17-059624
Insider Transaction Report
Form 4
Crombez Eric
Chief Medical Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2017-11-07−128,292→ 0 totalExercise: $0.56Exp: 2024-12-16→ Common Stock (128,292 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-11-07−80,396→ 0 totalExercise: $4.09Exp: 2025-06-02→ Common Stock (80,396 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-11-07−50,000→ 0 totalExercise: $7.14Exp: 2026-01-31→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2017-11-07−50,000→ 0 totalExercise: $1.90Exp: 2027-01-31→ Common Stock (50,000 underlying)
Footnotes (4)
- [F1]This stock option, which vests over four years beginning December 1, 2014, at a rate of 25% on December 17, 2015, and in 36 equal monthly installments thereafter, was assumed by Ultragenyx Pharmaceutical Inc. ("Ultragenyx"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the "Merger Agreement"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx.
- [F2]This stock option, which vested 8,375 shares on December 1, 2015, and vests in 43 equal monthly installments thereafter, beginning December 3, 2015, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement.
- [F3]This stock option, which vests in 48 equal monthly installments beginning January 27, 2016, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement.
- [F4]This stock option, which vests in 48 equal monthly installments beginning January 18, 2017, was assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement.
Documents
Issuer
Dimension Therapeutics, Inc.
CIK 0001592288
Entity typeother
Related Parties
1- filerCIK 0001653052
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 5:05 PM ET
- Size
- 13.1 KB